Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:31 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | 0.00% |
|
+3.45% | - |
| Market Cap | 77M 54.82M 46.94M 43.79M 40.19M 75.51M 5.25B 520M 203M 2.63B 206M 201M 8.7B | P/E 2027 * |
-6.52x | P/E 2028 * | -21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 59.1M 42.08M 36.03M 33.61M 30.84M 57.96M 4.03B 399M 155M 2.02B 158M 155M 6.68B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 5.64x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 week | +3.45% | ||
| Current month | +15.38% | ||
| 1 month | +7.14% | ||
| 3 months | +11.11% | ||
| 6 months | +22.45% |
| 1 week | 0.14 |  | 0.16 |
| 1 month | 0.12 | | 0.18 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/8/25 | Fiscal year | Chairman | 750,000 | 0.1933% | ||
| 9/8/25 | Free | Founder | 447,000 | 0.1152% | ||
| 9/8/25 | Fiscal year | Director | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +3.45% | -18.92% | +87.50% | 54.82M | |
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | |
| -0.50% | +20.62% | +52.92% | +93.12% | 64.66B | |
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | |
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| -0.44% | +5.18% | +35.45% | -14.55% | 19.98B | |
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | |
| Average | -0.26% | +5.91% | +51.13% | +188.81% | 28.72B | |
| Weighted average by Cap. | +0.16% | +8.21% | +58.91% | +160.69% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.76M 5.79M 5.4M 4.96M 9.32M 647M 64.1M 24.99M 324M 25.4M 24.84M 1.07B |
| Net income | -11.6M -8.26M -7.07M -6.6M -6.05M -11.38M -790M -78.27M -30.51M -396M -31.01M -30.34M -1.31B | -4.1M -2.92M -2.5M -2.33M -2.14M -4.02M -279M -27.66M -10.78M -140M -10.96M -10.72M -463M |
| Net Debt | -17.9M -12.74M -10.91M -10.18M -9.34M -17.55M -1.22B -121M -47.08M -611M -47.85M -46.81M -2.02B | -23.4M -16.66M -14.26M -13.31M -12.21M -22.95M -1.59B -158M -61.55M -799M -62.56M -61.2M -2.65B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | A$0.1500 | 0.00% | 707,959 |
| 26-08-20 | A$0.1500 | +3.45% | 321,518 |
| 26-08-19 | A$0.1450 | -6.45% | 80,111 |
| 26-08-18 | A$0.1550 | 0.00% | 318,833 |
| 26-08-17 | A$0.1550 | +6.90% | 514,599 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1500AUD
Average target price
0.4200AUD
Spread / Average Target
+180.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
